SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
HIVE Digital Technologies announced the appointment of Mark Volk as Senior Vice President, Revenue of BUZZ HPC, its wholly owned subsidiary. Volk brings extensive experience in AI/HPC commercialization and will lead the subsidiary's global go-to-market strategy and revenue scaling efforts.
View raw filing on EDGAR →The filing discloses the appointment of Admiral Michael S. Rogers to Innodata's Board of Directors, effective September 10, 2026. While the Item 5.02 section also includes compensatory arrangement details (annual fee of $75,000 and equity grant), the principal disclosed action is the election of a new independent director. The appointment of a high-profile former NSA Director and U.S. Cyber Command Commander to guide the company's Federal and AI security strategy is material to investors assessing the registrant's governance and strategic direction.
View raw filing on EDGAR →The filing discloses the appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, effective October 5, 2026. While the disclosure includes compensatory details (base salary of $500,000, target bonus of 60%, sign-on bonus of $150,000, and RSU grant of $350,000), the principal disclosed action is the appointment of a named executive to a key financial officer role. This is material as it addresses a significant leadership position and represents a change in the Company's accounting and financial reporting oversight structure.
View raw filing on EDGAR →The filing discloses the appointment of Jill Albertelli as president of Pratt & Whitney effective January 1, 2027, succeeding Shane Eddy. While the section also mentions Eddy's retirement, the principal disclosed action centers on Albertelli's appointment to a significant leadership role at a major RTX business unit. The press release emphasizes her qualifications and the strategic importance of the transition, making the appointment the salient event.
View raw filing on EDGAR →Legend Biotech's Board of Directors appointed Ingrid Zhang as Chief Executive Officer effective September 15, 2026, following a comprehensive Board-led search process. This is a material executive appointment of a named officer to a principal leadership role. Alan Bash, who served as Interim CEO since July 2026, resumes his role as President, CARVYKTI. The appointment of a new CEO from an external candidate with significant industry experience (former Chief Commercial Officer at Novartis) is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →David P. Yeager was appointed as Chairman and Chief Executive Officer effective September 13, 2026, and Patrick O'Donnell was appointed as Chief Financial Officer effective following the 10-K filing. These senior leadership appointments represent material changes during a period when the company is managing a financial restatement process.
View raw filing on EDGAR →LB Pharmaceuticals appointed Susan G. Kozauer, M.D. as Chief Medical Officer, effective September 14, 2026. Dr. Kozauer brings extensive neuropsychiatric drug development expertise and will play a critical role in advancing the company's lead product LB-102 toward Phase 3 NOVA-2 trial results expected in H1 2027. The appointment includes a base salary of $515,000, a sign-on bonus of $150,000, and a 200,000-share option grant.
View raw filing on EDGAR →Steven J. Delahunt was elected Chief Financial Officer by the Board of Directors effective October 1, 2026, replacing Erica McLaughlin who was promoted to President and CEO. Delahunt will serve in an interim capacity pending a permanent CFO search and will receive a $35,000 monthly stipend for his interim service.
View raw filing on EDGAR →Ellen Rubin was elected to Quanta Services' Board of Directors on September 9, 2026, increasing the board size from ten to eleven directors. She was assigned to the Audit Committee and Safety, Operations and Risk Committee, bringing technology, AI, and cybersecurity expertise to the board.
View raw filing on EDGAR →The filing discloses the appointment of Charles H. Fedalen, Jr. as a trustee of Fortress Credit Realty Income Trust effective September 15, 2026, to fill a vacancy created by James B. Perry's resignation. While both a departure and an appointment occur, the substantive disclosure centers on the appointment of a new board member with detailed background information (43-year real estate career, prior CFO and President roles at Irvine Company, Wells Fargo commercial real estate lending experience). This is a material governance event affecting board composition.
View raw filing on EDGAR →The filing discloses both a director resignation (Jeff T.C. Hsu, effective May 31, 2025) and the appointment of Tayi Shen to the Board effective September 14, 2026. While both events are disclosed under Item 5.02, the principal action emphasized in the prose is the appointment of Mr. Shen, a Vice President with extensive business development and strategic experience in defense and satellite communications sectors. The appointment of a new director with detailed background and qualifications is the salient event, making this an exec_appointment rather than exec_departure.
View raw filing on EDGAR →The filing discloses the appointment of Dr. Victoria Ivashina as an independent director and audit committee member, effective September 11, 2026. While the disclosure includes compensatory elements (share transfer at $0.003/share and standard director indemnity agreement), the principal disclosed action is the appointment of a new director to the board and audit committee. The extensive biographical detail and independence determination underscore the materiality of this governance change.
View raw filing on EDGAR →The exhibit announces the Board's appointment of Mr. Alfonso Camilo Barco Muñoz as Acting Chief Executive Officer, effective September 15, 2026. While the disclosure also mentions Mr. Juan Carlos Hurtado Parra's retirement, the principal disclosed action is the appointment of a new CEO, making this an exec_appointment event. The appointment of a chief executive is material to investors' assessment of the registrant's leadership and governance.
View raw filing on EDGAR →James H. Hegenbarth was declared director-elect to serve as a member director of the Federal Home Loan Bank of Chicago's Board of Directors for a four-year term beginning January 1, 2027. This is a clear appointment of a director to the Board, which is a material governance event affecting the composition of the registrant's leadership.
View raw filing on EDGAR →The filing discloses the appointment of Yossi Cohen, former Mossad Director and Israel's National Security Advisor, as President of Quantum X Labs' Scientific Advisory Board. The press release emphasizes Cohen's prominent background in national security and his current role as strategic advisor to SoftBank, positioning him to shape QXL's technological roadmap in quantum computing, sensing, and cybersecurity. This is a material executive appointment that would affect investor assessment of the company's strategic direction and credibility in defense/critical infrastructure markets.
View raw filing on EDGAR →The filing discloses the appointment of Yaniv Cohen as interim Chief Executive Officer of IR-Med, Inc., effective September 14, 2026. This is a material executive appointment to the company's top operational role. The disclosure includes Cohen's extensive background in medical device R&D, his co-founding of IR-Med Ltd., and his current role as Chief Scientific Officer, making this a significant leadership change that would affect investor assessment of the company's direction and management.
View raw filing on EDGAR →USA TODAY Co. appointed Timothy Allen, CEO of Babbel, to its Board of Directors effective September 15, 2026, expanding the board from eight to nine directors. Allen was also appointed to the Audit Committee and Transformation Committee.
View raw filing on EDGAR →The Board of Directors elected Cindy Yao as Vice President, Chief Financial Officer and Treasurer of Tredegar Corporation, effective September 21, 2026. Ms. Yao brings extensive experience as a public-company CFO and operating leader and will play a critical role in advancing the company's transformation initiatives and strengthening financial execution.
View raw filing on EDGAR →Gap Inc. appointed Kirsten Green, Founder and Managing Partner of Forerunner, to its Board of Directors effective September 15, 2026. Green is a prominent venture capital investor with over two decades of experience and recognition on the Forbes Midas List and TIME's 100 Most Influential People. The appointment includes compensatory arrangements consisting of stock units valued at $185,000 and a pro rata annual cash retainer.
View raw filing on EDGAR →The press release announces that Braden Jensen, the Company's Corporate Controller, has been appointed interim Chief Financial Officer effective September 15, 2026, following Carol Li's departure as CFO. While the disclosure includes both a departure (Li stepping down) and an appointment (Jensen taking the interim CFO role), the principal disclosed action is Jensen's appointment to the CFO position, supported by detailed background on his 15+ years in natural resources finance and prior CFO experience. The appointment of a CFO is material to investors' assessment of financial leadership and governance. The disclosure also mentions a stock option grant to Tom McMillan (VP, Investor Relations), which is a secondary compensation event within the same release.
View raw filing on EDGAR →Angel Javier Perez Jimenez was appointed as President, CEO, CFO, Treasurer, Secretary, and sole Director effective August 10, 2026, in connection with the change of control, following the resignation of Stephen Ken Adair from all positions.
View raw filing on EDGAR →Ben Letham was appointed as a Class I director and member of the Risk Committee, effective September 14, 2026, to fill a vacancy created by John Prince's passing. Letham brings expertise in AI and optimization systems from his role as a research scientist at Meta.
View raw filing on EDGAR →The filing discloses both the departure of Gary Vecchiarelli and the appointment of Marc Lasry to the Board of Directors, effective October 1, 2026. While both events occur, the appointment of Marc Lasry—a prominent investor with three decades of capital markets experience who previously backed the company as a startup in 2015—is the principal disclosed action and carries greater significance for investors. The filing emphasizes Lasry's qualifications, independence determination, and his prior relationship with the company, making the appointment the salient event.
View raw filing on EDGAR →Apogee elected three new directors to its Board: Joseph B. Hayek, Suresh Krishna, and Julie K. Streich, effective September 11, 2026. Julie K. Streich was appointed to the Audit Committee; Patricia K. Wagner retired effective October 2, 2026. The appointments materially affect board composition and governance oversight.
View raw filing on EDGAR →The filing discloses the appointment of James Barton as Executive Vice President, Commercial Growth & Operations, effective September 22, 2026, succeeding Lori Briggs. While Briggs's departure is also mentioned, the principal disclosed action centers on Barton's appointment to a named executive officer role. The press release emphasizes Barton's qualifications and strategic fit with the company's priorities, consistent with an exec_appointment classification.
View raw filing on EDGAR →The filing discloses the appointment of Ann Fogarty as Enterprise Chief Operating Officer, a C-suite executive role at State Street Corporation, effective immediately. While Mostapha Tahiri's appointment as President of State Street Alpha is also mentioned, the principal focus is Fogarty's elevation to the COO position, which is a material executive appointment affecting the registrant's leadership structure. The disclosure includes her compensation arrangement ($5,650,000 target incentive award) in connection with the appointment.
View raw filing on EDGAR →Kristoffer Hinson was appointed as Executive Vice President and Chief Financial Officer, effective April 1, 2027, succeeding Sunit Patel who is retiring from the CFO role effective March 31, 2027.
View raw filing on EDGAR →The filing discloses the election of Sabir Sami as a director of Chipotle effective immediately on September 14, 2026, with the Board increasing in size to 11 directors. Mr. Sami, a former CEO of KFC with 16 years at Yum! Brands and 30+ years of restaurant industry experience, brings significant operational expertise to the board. This is a material governance event affecting board composition and strategic direction.
View raw filing on EDGAR →Jereme Sylvain, EVP and Chief Financial Officer, was appointed by the Board to the expanded role of EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026, with expanded responsibilities overseeing global operations and quality teams.
View raw filing on EDGAR →Dr. Patrick Soon-Shiong and Mr. James Banaag were appointed as directors to the Board of PDS Biotechnology effective September 14, 2026, pursuant to board designation rights granted under the Securities Purchase Agreement with Nant Capital.
View raw filing on EDGAR →Check Point announced the appointment of Yoram Tietz to its Board of Directors. The disclosure explicitly states "Check Point Software Announces Appointment of Yoram Tietz to its Board of Directors" and provides biographical details of his qualifications, including his role as Senior Advisor at General Atlantic and his three decades of experience mentoring technology companies. Board appointments are material governance events affecting the composition of the registrant's leadership.
View raw filing on EDGAR →VinFast announced the appointment of Mr. Pham Nhat Quan Anh as Chief Executive Officer, effective September 12, 2026, succeeding Mr. Pham Nhat Vuong who remains on the Board. This is a material executive appointment at the C-suite level that would affect a reasonable investor's assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →The exhibit is a press release announcing the appointment of Andrew Davison as Chief Strategic Officer (CSO) of YYForce Inc., effective September 14, 2026. The disclosure explicitly states his new role will "spearhead YYForce's corporate strategy, direct portfolio governance, and oversee operational scaling initiatives," and emphasizes his 20+ years of executive leadership experience in scaling organizations and operational transformations. This is a clear executive appointment of a named officer to a material leadership position.
View raw filing on EDGAR →The filing announces the appointment of Aldo Uva to Natuzzi's Board of Directors, with the Board expected to formally appoint him as Chief Executive Officer within the first half of October 2026. This is a material executive appointment of a new CEO to lead the company's "industrial and operational turnaround," replacing prior leadership. The disclosure emphasizes his 30+ years of executive experience and prior tenure as Natuzzi CEO (May 2008–March 2009), making this a significant governance and leadership change material to investors.
View raw filing on EDGAR →Brian Ezzell was appointed as Senior Vice President and Chief Financial Officer effective October 1, 2026, succeeding Amy Schwetz. The appointment includes a $625,000 base salary, 75% cash incentive target, $1.6M long-term incentive target, and one-time equity grants totaling $400,000.
View raw filing on EDGAR →Q32 Bio appointed José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer. Both appointments are material to the clinical-stage biotech company as these key leadership roles directly oversee clinical development and regulatory strategy for the company's late-stage clinical program (bempikibart in Phase 2 for alopecia areata).
View raw filing on EDGAR →The filing discloses the appointment of Richard B. Lewis to Graco's Board of Directors, effective December 3, 2026, with assignment to the Audit Committee. This is a clear director appointment under Item 5.02, representing a material governance change that would affect a reasonable investor's assessment of board composition and oversight. The press release confirms his appointment and highlights his operational and commercial experience as CEO of Donaldson Company.
View raw filing on EDGAR →The filing discloses the appointment of two new directors, R. Duane Clark II and James Sapirstein, to INmune Bio's Board of Directors on September 8, 2026. Item 5.02 explicitly covers this appointment, and the prose emphasizes their extensive experience in rare-disease commercialization and business development—capabilities directly aligned with the company's advancement of Ebstrocel toward potential commercialization. This is a material governance event affecting board composition and strategic direction.
View raw filing on EDGAR →The filing discloses both the termination of Paul Krzywicki as CFO (effective September 24, 2026) and the appointment of Jessica Paz as Chief Accounting Officer (effective September 8, 2026). While both events are disclosed, the principal focus and substantive content centers on Ms. Paz's appointment, including detailed terms of her employment offer (base salary of $215,000, 50,000 stock option grant with four-year vesting), indemnification agreement, confidentiality agreement, and extensive background. The termination of Mr. Krzywicki is noted briefly as non-contentious. The appointment is material as it involves a named executive officer and significant equity compensation.
View raw filing on EDGAR →The press release announces the appointment of Asaf Silberstein, Executive Vice President and Chief Operating Officer of Semtech Corporation, to Valens Semiconductor's Board of Directors. This is a clear executive/director appointment disclosed in a press release dated September 14, 2026. The appointment of a senior industry executive with two decades of semiconductor leadership experience to the board is material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →The 6-K discloses the appointment of Ms. Christina Ching as Chief Financial Officer, effective September 14, 2026. She transitions from Interim CFO (since May 2024) to permanent CFO. This is a material executive appointment of a named officer to a C-suite position, affecting the registrant's financial leadership and governance structure.
View raw filing on EDGAR →Heidi O'Neill was appointed as Chief Executive Officer effective September 8, 2026, and concurrently appointed to the Board as a Class II director. The interim co-CEOs Meghan Frank and Andre Maestrini ceased service upon O'Neill's commencement.
View raw filing on EDGAR →The filing discloses the appointment of Josef Bilant as Chief Operating Officer, effective October 5, 2026, approved by the Board on September 8, 2026. This is a material executive appointment to a senior officer position. While the disclosure also includes compensatory arrangements (base salary of $330,000, sign-on bonus, performance bonus eligibility, and separation benefits), the principal disclosed action is the appointment itself, making exec_appointment the most salient classification.
View raw filing on EDGAR →Chatham Lodging Trust appointed William P. (Liam) Brown to its Board of Trustees effective September 10, 2026, as an independent director. Brown brings 37 years of lodging industry experience from Marriott, most recently as Group President of United States and Canada operations overseeing 6,000+ hotels, representing a material governance enhancement and addition of deep operational expertise.
View raw filing on EDGAR →Kevin Hefner was elected as a director to fill a vacancy on the Board of Directors effective September 8, 2026, and appointed to the Audit Committee and as chairman of the Compensation and Governance Committee.
View raw filing on EDGAR →The filing discloses the appointment of Larry G. Paige II as a Class III director effective September 8, 2026, filling an existing vacancy, along with his appointment to the Audit Committee, Compensation Committee, and as chair of the Nominating and Corporate Governance Committee. This is a clear executive appointment event. The disclosure includes his extensive background spanning military service, federal contracting, and program management, and the Board's determination that he qualifies as an independent director, making this material to investors' assessment of board composition and governance.
View raw filing on EDGAR →Richard H. Parry was appointed as a Class II director of Bimini Capital Management on September 14, 2026, with a term expiring in 2029. This is a clear executive appointment under Item 5.02. The appointment is material because Parry is the President and Chief Investment Officer of TJIM, an 80%-owned subsidiary acquired by the Company in April 2026 for $12.3 million, and his board seat reflects the strategic importance of that acquisition to the Company's asset management diversification.
View raw filing on EDGAR →The filing discloses the appointment of Dongwei Li as an independent director and Audit Committee Chair effective September 11, 2026, following the resignation of Changzheng Ye on September 8, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new director to fill the vacancy, with detailed biographical information and compensation terms ($25,000 annually). This is material to investors as it affects board composition and audit oversight.
View raw filing on EDGAR →The filing discloses the appointment of Larry King as Chief Financial Officer effective September 14, 2026, and Heather Clayton as Chief Accounting Officer effective September 28, 2026. While the filing also mentions the departure of Martin Costas as CFO, the principal disclosed actions center on the two new appointments with detailed biographical information and compensation terms ($300,000 and $250,000 annual salaries respectively). These are material executive appointments to key financial officer roles.
View raw filing on EDGAR →The filing discloses the appointment of Kanishka Ragula as Chief Financial Officer and Principal Accounting Officer effective September 11, 2026, following the departure of Eric Sherb. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO with detailed background and compensation terms ($175,000 base salary plus equity grant). The appointment of a CFO is material to investors assessing the registrant's financial leadership and strategic direction.
View raw filing on EDGAR →